Biotech innovation runs on sensitive data, genetic sequences, clinical trial results, and proprietary formulations. But in today’s threat landscape, that data is under constant attack. It’s not just foreign-states looking to steal IP. Ransomware gangs, phishing attackers, and insider threats are evolving faster than most life sciences companies can react.
That’s why Single Point of Contact delivers more than monitoring and compliance checklists. We help biotech organizations test their defenses through simulated real-world attacks exposing security flaws before attackers do.
Welcome to offensive security testing a must-have for any C-suite leader managing genomics research, CRO operations, or clinical data environments.
Offensive Security: Going Beyond Compliance
Many biotech firms assume that passing a compliance audit means they’re secure. That’s a dangerous misconception. Compliance is baseline, not bulletproof.
Offensive security flips the script. Instead of asking, “Are we compliant?” it asks, “Could an attacker break in, pivot laterally, and access our most valuable data?”
And for C-suite executives, this means gaining true risk visibility across lab environments, third-party systems, and under-the-radar vulnerabilities.
Why Biotech Labs Are an Ideal Target
Biotech firms operate in a high-stakes, high-reward ecosystem which makes them uniquely vulnerable.
- Ransomware groups know that delays in research or clinical trials have huge financial consequences.
- IP thieves understand the long-term value of genetic data and pharmaceutical formulations.
- Phishing campaigns exploit fast-moving teams with little time for cybersecurity training.
- Insider threats go unnoticed due to the open, collaborative nature of many lab environments.
The combination of cutting-edge science, complex IT infrastructure, and intense time pressure creates a perfect storm for exploitation.
Where Traditional Security Falls Short
Even with firewalls, antivirus, MFA, and endpoint detection tools in place, biotech organizations often miss the bigger picture. Offensive testing is designed to mimic how attackers move across systems, through users, and between cloud environments.
Common gaps uncovered through offensive security include:
- Over-permissioned lab users with access to production or admin-level systems
- Unpatched research equipment with outdated firmware or exposed APIs
- Cloud misconfigurations in platforms like AWS or Azure used for genomic computation
- Lack of network segmentation between lab devices and business applications
- Weak social engineering defenses that allow phishing or pretexting to succeed
- Missed lateral movement paths, where one compromised user can open access to core systems
What Biotech Executives Should Demand from Offensive Testing
To be effective, offensive testing in a life sciences setting must be built around real-world lab operations not just IT environments.
Here’s what that looks like:
- Simulated spear-phishing attacks on lab staff
Your researchers handle critical data but may lack security awareness. Testing their response provides invaluable insight. - Physical access testing of lab or clinical research facilities
Can someone tailgate into a secure zone? Can devices be accessed directly? - Custom red teaming that targets IP and PHI
Simulate what a motivated attacker might do to steal your core assets or delay clinical outcomes. - Cloud attack simulation for genomic data repositories
Identify privilege escalation paths, misconfigurations, and access token misuse. - Attack chaining assessments
Test how vulnerabilities in combination not isolation could compromise your environment.
The result? Executives gain an executive-ready threat landscape report highlighting what’s exploitable, what’s urgent, and what must be addressed before it’s too late.
Actionable Outcomes: What You Get from Offensive Testing
Offensive testing isn’t just about finding flaws it’s about making decisions with confidence. Here’s what you walk away with:
- A risk-prioritized remediation roadmap tailored to biotech workflows
- Evidence for FDA, HIPAA, and GDPR compliance documentation
- Data to enhance your incident response planning
- Input for cyber insurance validation and risk underwriting
- Insights for training R&D staff and non-technical teams
This isn’t just about security it’s about business continuity, reputation management, and investor confidence.
What’s the Cost of Doing Nothing?
Many biotech companies still rely on a reactive model: wait for an alert, then scramble to respond. That approach is risky and expensive.
A single ransomware event or data breach could cost millions, delay product release, or jeopardize FDA trials. Worse, your IP could be silently stolen and sold to a competitor or foreign government.
Proactive offensive testing gives you control. It flips the power dynamic from defense to offense and helps your leadership team make informed, forward-thinking decisions.
Partnering with the Right Security Team
Single Point of Contact supports life sciences leaders who understand that protecting innovation is non-negotiable.
Our 24×7 SOC monitoring provides visibility into threats. Our incident response services help you recover quickly. And our compliance-aligned offensive security testing identifies the vulnerabilities that matter most before they’re exploited.
If your genomics lab, CRO, or clinical trial organization is ready to strengthen its defenses with the mindset of an attacker let’s talk.
Contact us today to schedule a consult.
About Single Point of Contact
Single Point of Contact is an experienced MSP in the biotech industry and is a valuable partner, providing specialized knowledge in implementing robust backup strategies and ensuring network security and stability. With deep understanding of regulatory requirements such as HIPAA and FDA’s 21 CFR Part 11, Single Point of Contact safeguards sensitive research data, clinical trial information, and intellectual property. They offer tailored solutions, including automated backups, real-time monitoring, and disaster recovery plans, minimizing downtime and data loss. By managing security protocols, they protect against cyber threats, allowing biotech companies to focus on innovation while ensuring compliance and uninterrupted operations. This expertise enhances productivity and reduces risk. Contact us today to discover more about how we can help your biotech firm with DR, backup and security.
